Welcome to our dedicated page for Theratechnologies news (Ticker: THTX), a resource for investors and traders seeking the latest updates and insights on Theratechnologies stock.
Theratechnologies Inc. was a commercial-stage biopharmaceutical company whose recent news covered product commercialization, financial results, shareholder matters and a completed acquisition. Company updates included the availability of EGRIFTA WR™ (tesamorelin) for injection, an FDA-approved formulation used to reduce excess abdominal fat in adults with HIV and lipodystrophy.
Theratechnologies news also covered quarterly operating results, regulatory and development spending categories, proxy and shareholder voting matters, capital-structure disclosures and governance matters tied to its transition following the completed acquisition by an affiliate of Future Pak.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.